Novocure PANOVA-4 Trial Shows Positive Cancer Results
Baar, Switzerland – March 2026 Novocure announced positive topline results from its Phase 2 PANOVA-4 clinical trial evaluating Tumor...
Pancreatic Cancer
Advertisement
FAPI-74 Phase 3 Trial Doses First Pancreatic Patient
DULLES, Va., Feb. 11, 2026 — SOFIE Biosciences announced that the first patient has been dosed in its Phase...
Autonomix Reports Rapid, Durable Pain Relief in Pancreatic Cancer
THE WOODLANDS, Texas | January 9, 2026 — Autonomix Medical, Inc. has reported compelling proof-of-concept (PoC) clinical data demonstrating...
Alligator to Present New Mitazalimab Data at ASCO GI 2026
LUND, Sweden | January 9, 2026 — Alligator Bioscience announced that new clinical data from its Phase 1b/2 OPTIMIZE-1...
Morphocell Secures $50M to Advance Stem-Cell Liver Therapy
Laval, Québec, December 1, 2025 — Morphocell Technologies has announced the successful completion of its US$50 million Series A...
Advertisements
Can-Fite Highlights Major Progress Across Late-Stage Drug Pipeline
Ramat Gan, Israel, November 26, 2025 — Can-Fite BioPharma has announced key updates across its advanced-stage clinical pipeline ahead...
Renovo Rx Showcases Targeted Oncology Innovation at MedTech Forum
MOUNTAIN VIEW, Calif., November 4, 2025 — RenovoRx, Inc. (NASDAQ: RNXT), a life sciences company pioneering targeted oncology therapies...
Oncolytics Prepares Registration Trial in First-Line Pancreatic Cancer
SAN DIEGO, Sept. 29, 2025 — Oncolytics Biotech® Inc. (NASDAQ: ONCY) today announced a key update on its plan...
FDA Grants Orphan Drug Designation to Utidelone for Pancreatic Cancer
SAN FRANCISCO, Sept. 25, 2025 — Biostar Pharma’s core anticancer drug Utidelone has been granted Orphan Drug Designation (ODD)...
Silexion’s SIL204 Shows Preclinical Promise in Pancreatic Cancer
GRAND CAYMAN, Cayman Islands, Sept. 11, 2025 – Silexion Therapeutics Corp. (NASDAQ: SLXN), a clinical-stage biotechnology company developing RNA...
Advertisement
